Provectus Biopharmaceuticals, Inc. SEC filings PVCT
Provectus Biopharmaceuticals, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Jul 28, 2004. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jul 1, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Mar 6, 2017 | — |
| 424B3 | Prospectus | Feb 21, 2017 | — |
| 424B3 | Prospectus | Feb 9, 2017 | — |
| 424B4 | Prospectus | Jan 31, 2017 | — |
| S-1/A | Amended registration statement | Jan 26, 2017 | — |
| S-1/A | Amended registration statement | Jan 19, 2017 | — |
| S-1/A | Amended registration statement | Dec 21, 2016 | — |
| S-1/A | Amended registration statement | Dec 6, 2016 | — |
| S-1/A | Amended registration statement | Nov 22, 2016 | — |
| S-1/A | Amended registration statement | Nov 1, 2016 | — |
| S-1 | Registration statement | Oct 5, 2016 | — |
| 424B5 | Prospectus supplement | Aug 26, 2016 | — |
| 424B5 | Prospectus supplement | Aug 24, 2016 | — |
| 424B3 | Prospectus | Jun 1, 2016 | — |
| S-4 | Registration for a merger or exchange | May 13, 2016 | — |
| POS AM | Filing | May 9, 2016 | — |
| 424B3 | Prospectus | Mar 7, 2016 | — |
| 424B3 | Prospectus | Jan 20, 2016 | — |
| FWP | Free writing prospectus | Jan 14, 2016 | — |
| S-4/A | Amendment no. 1 to form s-4 | Jan 14, 2016 | — |
| S-4 | Registration for a merger or exchange | Dec 31, 2015 | — |
| S-3 | Shelf registration | Jul 16, 2015 | — |
| 424B5 | Prospectus supplement | Jun 19, 2015 | — |
| 424B3 | Prospectus | Jun 19, 2015 | — |
| 424B5 | Prospectus supplement | Jun 19, 2015 | — |
| 424B3 | Prospectus | May 8, 2014 | — |
| 424B5 | Prospectus supplement | Apr 30, 2014 | — |
| 424B3 | Prospectus | Apr 30, 2014 | — |
| 424B3 | Prospectus | Nov 12, 2013 | — |
| 424B3 | Prospectus | Aug 8, 2013 | — |
| 424B5 | Prospectus supplement | Jul 26, 2013 | — |
| 424B3 | Prospectus | May 10, 2013 | — |
| 424B3 | Prospectus | Apr 16, 2013 | — |
| S-1 | Registration statement | Apr 8, 2013 | — |
| POS AM | Form pos am | Apr 8, 2013 | — |
| POS AM | Form pos am | Apr 8, 2013 | — |
| FWP | Free writing prospectus | Oct 23, 2012 | — |
| 424B5 | Prospectus supplement | Sep 4, 2012 | — |
| S-3 | Shelf registration | Jul 2, 2012 | — |
| S-3 | Shelf registration | Jul 15, 2011 | — |
| 424B5 | Prospectus supplement | Jan 13, 2011 | — |
| 424B5 | Prospectus supplement | Dec 23, 2010 | — |
| POS AM | Pvct pos am 07-26-10 | Jul 27, 2010 | — |
| S-3/A | Pvct s-3/a2 07-22-10 | Jul 26, 2010 | — |
| S-3/A | Pvct s-3/a 07-08-10 | Jul 12, 2010 | — |
| S-3 | Shelf registration | Jun 30, 2010 | — |
| 424B3 | Prospectus | Apr 5, 2010 | — |
| 424B3 | Prospectus | Nov 17, 2009 | — |
| 424B3 | Prospectus | Aug 13, 2009 | — |
| 424B3 | Prospectus | Jun 29, 2009 | — |
| POS AM | Pvct post-effective amendment no. 1 | May 5, 2009 | — |
| S-1/A | Amended registration statement | May 1, 2009 | — |
| S-2/A | Amendment no. 1 | Jun 14, 2005 | — |
| S-2 | Registration statement | May 16, 2005 | — |
| S-2/A | Filing | Nov 10, 2004 | — |
| S-2/A | Filing | Nov 5, 2004 | — |
| S-2 | Registration statement | Oct 7, 2004 | — |
Showing 57 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PVCT (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Knoxville, TN
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 315545
- Former names
- PROVECTUS PHARMACEUTICALS INC (until Dec 18, 2013); PROVECTUS PHARMACEUTICAL INC (until May 15, 2002); ZAMAGE DIGITAL IMAGING INC (until Apr 1, 2002); SPM GROUP INC (until Nov 14, 2001)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.